RxDoctor Payments Data

John Lee, MD

Orthopaedic Surgery · Baldwin Park, CANPI 1407083348

Payments from drug & device makers

$3,852in general payments, 2019–2025

Across 65 payments — averaging $59.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$3K
  • Smith+Nephew$156
  • Amgen$133
  • Si-bone, Inc.$64
  • Kerecis Limited$31
  • Polaris Technology Solutions LLC$22
  • plus $34 from 2 others

What the payments were for

  • Travel & lodging$92524%
  • Food & beverage$2,77172%
  • Education$1564%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Stryker57$3,411
Smith+Nephew1$156
Amgen1$133
Si-bone, Inc.2$64
Kerecis Limited1$31
Polaris Technology Solutions LLC1$22
Orthofix Medical, Inc.1$18
Zimmer Biomet1$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,852 in reported general payments places this provider in the 55th percentile of 1,808 orthopaedic surgery providers in California.

See all orthopaedic surgery providers in California

Medicare billing

Part B allowed, 2024
$331,710
Medicare patients
403
Services billed
3,136

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib94$7,763
Naloxone Hcl20$1,092
Oxycodone Hcl154$952
Diclofenac Sodium46$545
Meloxicam148$486
Naproxen16$267
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen30$250
Tramadol Hcl75$225
Ibuprofen35$189
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen37$171
Gabapentin11$55

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Baldwin Park

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →